Synapse - Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL

Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL Meeting Abstract

Authors:	Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; Pandit-Taskar, N.; Divgi, C.; Zelenetz, A. D.
Abstract Title:	Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
Meeting Title:	47th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	106
Issue:	11 Pt. 1
Meeting Dates:	2005 Dec 10-13
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2005-11-01
Start Page:	272A
Language:	English
ACCESSION:	WOS:000233426001395
PROVIDER:	wos
PUBMED:	16342400
DOI:	10.1182/blood.V106.11.926.926
Notes:	--- - Meeting Abstract: 926 - 47th Annual Meeting of the American-Society-of-Hematology - DEC 10-13, 2005 - Atlanta, GA - Part 1 - "Source: Wos"